AbbVie Inc.

Stocks

ABBV

US00287Y1091

Market Closed - NYSE Other stock markets 04:04:49 2026-07-15 pm EDT			5-day change	1st Jan Change
244.11 ^USD	+0.44%		-3.41%	+6.84%

Jul. 15	Citigroup Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating	MT
Jul. 13	BMO Capital Adjusts Price Target on AbbVie to $300 From $258, Maintains Outperform Rating	MT

Transcript : AbbVie Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10

Published on 06/09/2026 at 12:05 pm EDT - Modified on 07/15/2026 at 08:08 am EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Asad Haider (Analysts)

All right. We're just about at time. So we can kick off our next session with AbbVie. Very excited to have the whole AbbVie management team over here with us.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about AbbVie Inc.

Jul. 15	Citigroup Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating	MT
Jul. 13	BMO Capital Adjusts Price Target on AbbVie to $300 From $258, Maintains Outperform Rating	MT
Jul. 13	UBS Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating	MT
Jul. 10	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says	MT
Jul. 10	BofA Securities Adjusts AbbVie Price Target to $276 From $234	MT
Jul. 10	AbbVie's Q2 Results Expected to be Inline With Expectations, RBC Says	MT
Jul. 10	RBC Raises Price Target on AbbVie to $280 From $260, Keeps Outperform Rating	MT
Jul. 10	Wells Fargo Adjusts Price Target on AbbVie to $295 From $260	MT
Jul. 09	JPMorgan Adjusts Price Target on AbbVie to $280 From $260	MT
Jul. 09	Guggenheim Adjusts Price Target on AbbVie to $261 From $249	MT
Jul. 08	Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says	MT
Jul. 08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
Jul. 08	Morgan Stanley Adjusts Price Target AbbVie to $279 From $278, Maintains Overweight Rating	MT
Jul. 07	Global markets live: Broadcom, Meta, Walmart, Intel, AbbVie…
Jul. 07	Tech Stock Decline, Oil Price Increase Dampen US Equity Futures Pre-Bell	MT